40 Participants Needed

In-home Cycling for Parkinson's Disease

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment In-home Cycling for Parkinson's Disease?

Research shows that cycling, including in-home and community-based programs, can help improve symptoms of Parkinson's disease. Studies found that regular cycling can lead to better motor function, balance, and coordination, and may slow disease progression.12345

Is in-home cycling safe for people with Parkinson's disease?

The research on cycling for Parkinson's disease does not report specific safety concerns or adverse events, suggesting it is generally safe. However, many studies did not report on adverse events, so it's important to consult with a healthcare provider before starting any new exercise program.24567

How does in-home cycling treatment differ from other treatments for Parkinson's disease?

In-home cycling for Parkinson's disease is unique because it allows patients to engage in exercise at home, potentially increasing accessibility and adherence compared to facility-based programs. This treatment focuses on high-cadence cycling, which has been shown to improve motor symptoms like tremor and bradykinesia (slowness of movement) in Parkinson's patients, offering a non-drug approach to managing symptoms.23568

What is the purpose of this trial?

This study seeks to examine the reach and maintenance of an in-home cycling program for underserved individuals with Parkinson disease and to determine the effectiveness of a 6-month in-home, progressive, tele-exercise cycling program and 3-month health coach follow-up for those same participants.

Research Team

KA

Kristen A Pickett, PhD

Principal Investigator

University of Wisconsin, Madison

Eligibility Criteria

This trial is for individuals with Parkinson's Disease who are underserved and interested in an at-home cycling program. Participants will engage in a 6-month tele-exercise cycling routine, followed by a 3-month period with optional health coaching.

Inclusion Criteria

I have been diagnosed with Parkinson's disease.
My vision is 20/40 or better, with or without glasses.
English speaking
See 3 more

Exclusion Criteria

Contraindication for exercise
I can commit to the full duration of the study.
Currently exercising for 20 or more minutes per week
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 6-month in-home, progressive, tele-exercise cycling program with social interaction via Skype

6 months
Regular virtual sessions via Skype

Follow-up

Participants receive a 3-month follow-up with a health coach to discuss maintenance efforts and motivation

3 months
Biweekly calls with health coach

Follow-up (No Health Coach)

Participants are contacted monthly to record falls, with no discussion of ongoing exercise

3 months
Monthly contact for fall recording

Treatment Details

Interventions

  • In-home Cycling
Trial Overview The study tests the effectiveness of two approaches: one group participates in social cycling sessions along with regular coaching calls, while another group cycles without any coaching calls.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Social Cycling GroupExperimental Treatment1 Intervention
Exercise bike delivered to their home, custom fit to their needs and installed in a safe location, sessions will consist of up to 30 minutes of cycling while engaged in social interaction with a research staff member, thus providing a social/community aspect that would not otherwise be present.
Group II: Biweekly health coachExperimental Treatment1 Intervention
Following completion of the 6-month cycling intervention, participants will receive a call every 2-weeks to discuss ongoing maintenance efforts.
Group III: Normal care controlActive Control1 Intervention
Participants assigned to the normal care control will receive no intervention for the first 6-months then cross over to the cycling intervention.
Group IV: No health coachActive Control1 Intervention
Following the conclusion of the 6-month cycling session, participants will be contacted monthly to record falls. No discussion of ongoing exercise will occur

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

Findings from Research

Persons with Parkinson's disease (PD) and age-matched healthy adults both increased their pedaling rates while cycling in a virtual environment (VE) with auditory and visual cues, indicating that these cues can effectively enhance exercise intensity.
However, individuals with PD needed explicit instructions to focus on visual cues to increase their cycling speed, suggesting that attention to cues is crucial for this group to benefit from the exercise intervention.
Auditory and visual cueing modulate cycling speed of older adults and persons with Parkinson's disease in a Virtual Cycling (V-Cycle) system.Gallagher, R., Damodaran, H., Werner, WG., et al.[2018]
In a 6-month community-based cycling program for 41 participants with Parkinson's disease, significant improvements were observed in motor function, as indicated by a decrease in the MDS-UPDRS-III score, suggesting that aerobic exercise can help slow disease progression.
Participants who attended at least 74% of the cycling classes experienced the greatest benefits, highlighting the importance of consistent exercise attendance and maintaining a higher pedaling cadence for mitigating Parkinson's symptoms.
Community-based high-intensity cycling improves disease symptoms in individuals with Parkinson's disease: A six-month pragmatic observational study.Rosenfeldt, AB., Miller Koop, M., Penko, AL., et al.[2023]
Passive leg cycling significantly reduces tremor and bradykinesia in individuals with mild-to-moderate Parkinson's disease, indicating a potential therapeutic benefit for upper extremity motor function.
The rate of passive cycling (60, 70, or 80 rpm) did not influence the level of improvement in motor function, suggesting that the benefits of passive cycling may be consistent regardless of speed.
Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson's disease.Ridgel, AL., Muller, MD., Kim, CH., et al.[2011]

References

Immediate Effects of High-Cadence Cycling on Core Outcomes in Individuals With Parkinson's Disease. [2023]
Effects of a low-resistance, interval bicycling intervention in Parkinson's Disease. [2018]
Auditory and visual cueing modulate cycling speed of older adults and persons with Parkinson's disease in a Virtual Cycling (V-Cycle) system. [2018]
Community-based high-intensity cycling improves disease symptoms in individuals with Parkinson's disease: A six-month pragmatic observational study. [2023]
Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson's disease. [2011]
Active-assisted cycling improves tremor and bradykinesia in Parkinson's disease. [2022]
Exercise and motor training in people with Parkinson's disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials. [2021]
A Tandem Cycling Program: Feasibility and Physical Performance Outcomes in People With Parkinson Disease. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security